AMBU B Ambu A/S Class B

AMBU FINANCIAL CALENDAR FOR 2023/24

AMBU FINANCIAL CALENDAR FOR 2023/24

This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 



2023

8 NOVEMBER 2023 Annual Report 2022/23
13 DECEMBER 2023 Annual General Meeting 2023



2024

30 JANUARY 2024 Earnings release Q1 2023/24
14 MAY 2024 Earnings release Q2 2023/24
30 AUGUST 2024 Earnings release Q3 2023/24
30 SEPTEMBER 2024 End of fiscal year 2023/24
5 NOVEMBER 2024 Annual Report 2023/24
4 DECEMBER 2024 Annual General Meeting 2024



The deadline for the inclusion of specific items on the agenda for the Annual General Meeting 2023 is 31 October 2023.





Ambu A/S

Baltorpbakken 13

2750 Ballerup

Denmark

Tel.

CVR no.: 63 64 49 19



CONTACT INFORMATION

Media

Tine Bjørn Schmidt

Head of Corporate Communications







Investors

Anders Hjort

Head of Investor Relations





ABOUT AMBU

Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,500 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.

Attachment



EN
29/09/2023

Underlying

AMBU BAmbu A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ambu A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B Ambu A/S Class ...

Flattening revenues AND bulky valuation

Q2 largely inline with pre-announcement. Q2 was the peak for growth, H2 revenues flattening out. At 71x P/E Ambu needs time to grow into its bulky valuation.

AMBU B AMBU A/S CLASS B
05/15/24 May 15, 2024 1 EN
Jesper Ingildsen
  • Jesper Ingildsen
Free Trial
AMBU B Ambu A/S Class ...

Ambu (Buy, TP: DKK138.00) - Guidance still looks conservative

Having pre-released Q2 headline numbers and increased the 2024 guidance in mid-April, today’s detailed results provided few surprises. However, the important Endoscopy sales were slightly better than expected, and we find today’s guidance for >15% organic growth YOY (previously c15%) for that part of company still conservative, with potential for a further rise with the Q3 results. We reiterate our BUY and have increased our target price to DKK138 (130).

AMBU B AMBU A/S CLASS B
05/14/24 May 14, 2024 1 EN
Free Trial
AMBU B Ambu A/S Class ...

Ambu AS: 1 director

A director at Ambu AS bought 12,500 shares at 118.560DKK and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

AMBU B AMBU A/S CLASS B
02/09/24 February 9, 2024 1 EN
 PRESS RELEASE
Free
AMBU B Ambu A/S Class ...

Ambu A/S: Reporting of transactions made by persons discharging manage...

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S.   The attached document discloses the data of the transactions made in Ambu shares.  Attachment

February 9, 2024 1 EN
 PRESS RELEASE
Free
AMBU B Ambu A/S Class ...

GRANT OF PERFORMANCE SHARE UNITS

GRANT OF PERFORMANCE SHARE UNITS Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February 2024 with retroactive effect from 1 January 2024. 49,109 of the PSUs have been granted to the Executive Management and 123,847 of the PSUs have been granted to other key employees.  The LTIP covers the financial year 2023/24, and the final allocation of PSUs is conditional upon achievement of two key performance indicators (organic revenue growth and EBIT marg...

February 6, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch